MN
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion | Biology of blood and marrow transplantation | 2014 | 585 | 1 | |||
Leucémie lymphoïde chronique : quand débuter le traitement ? | Revue médicale suisse | 2013 | 641 | 1 | |||
Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT | Bone marrow transplantation | 2012 | 777 | 0 | |||
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 1,024 | 584 | |||
Invasive microsporidiosis in allogeneic haematopoietic SCT recipients | Bone marrow transplantation | 2010 | 554 | 0 | |||
Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors | Blood | 2003 | 309 | 101 | |||
Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells | British journal of haematology | 2002 | 134 | 180 | |||
Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC | Transfusion | 2002 | 237 | 0 |